Cargando…

Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer

OBJECTIVE: Tumor microenvironment as an important element of malignancy could help predict cancer prognosis and therapeutic response; thus, a prognostic landscape map of the tumor microenvironment in luminal B breast cancers should be developed. METHODS: The GEO and TCGA databases were employed to r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Ji, Ren, Jia, Zheng, Jie, Zhang, Fuliang, Han, Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886761/ https://www.ncbi.nlm.nih.gov/pubmed/35242245 http://dx.doi.org/10.1155/2022/5621441

Ejemplares similares

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer
por: Lyu, Lijuan, et al.
Publicado: (2020)

Luminal B breast tumors are not HER2 positive
por: Bhargava, Rohit, et al.
Publicado: (2008)

Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2021)

The molecular profile of luminal B breast cancer
por: Creighton, Chad J
Publicado: (2012)

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
por: Cheang, Maggie C. U., et al.
Publicado: (2009)

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer
por: Aogi, Kenjiro, et al.
Publicado: (2015)

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012)

Analysis of the Potent Prognostic Factors in Luminal-Type Breast Cancer
por: Kim, Han-Sung, et al.
Publicado: (2012)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer
por: Tan, Jie, et al.
Publicado: (2018)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
por: Peng, Yang, et al.
Publicado: (2021)

Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China
por: Tang, Li-Chen, et al.
Publicado: (2015)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis
por: Li, Cheukfai, et al.
Publicado: (2022)

Luminal-B breast cancer and novel therapeutic targets
por: Tran, Ben, et al.
Publicado: (2011)

Luminal B breast tumors are not HER2 positive – authors' response
por: Tamimi, Rulla M, et al.
Publicado: (2008)

Inference of tissue relative proportions of the breast epithelial cell types luminal progenitor, basal, and luminal mature
por: Bartlett, Thomas E., et al.
Publicado: (2021)

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
por: Reynisdottir, Inga, et al.
Publicado: (2013)

Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2018)

A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer
por: Zhang, Zhihao, et al.
Publicado: (2022)

Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age
por: Majid, Runnak A, et al.
Publicado: (2017)

Probing the luminal microenvironment of reconstituted epithelial microtissues
por: Cerchiari, Alec E., et al.
Publicado: (2016)

Establishment and Validation of Novel Clinical Prognosis Nomograms for Luminal A Breast Cancer Patients with Bone Metastasis
por: Tu, QiHao, et al.
Publicado: (2020)

The molecular diversity of Luminal A breast tumors
por: Ciriello, Giovanni, et al.
Publicado: (2013)

Luminal B breast cancer: patterns of recurrence and clinical outcome
por: Li, Zhi-hua, et al.
Publicado: (2016)

Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
por: Viale, Giuseppe, et al.
Publicado: (2019)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2023)

The reciprocal influences of prognosis between two types of surgical interventions and early breast cancer patients with diverse luminal subtypes: A meta-analysis
por: He, Lin, et al.
Publicado: (2019)

PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B
por: Raj-Kumar, Praveen-Kumar, et al.
Publicado: (2019)

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
por: Tan, Shirong, et al.
Publicado: (2021)

Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Cuproptosis-Related genes in the prognosis of colorectal cancer and their correlation with the tumor microenvironment
por: Wu, Weiqiang, et al.
Publicado: (2022)

Systematic analysis of the cuprotosis in tumor microenvironment and prognosis of gastric cancer
por: Wang, Ke-wei, et al.
Publicado: (2023)

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression
por: Pellegrino, Benedetta, et al.
Publicado: (2021)

Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer
por: Borcherding, Nicholas, et al.
Publicado: (2015)

Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors
por: Cusan, Martina, et al.
Publicado: (2018)

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer
por: Viotto, Davide, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6dhmilrk3im075tucbdu1fs6o7